dataService

您的位置: 首页 > 数据服务 > 数据列表页

筛选

共检索到66条 ,权限内显示50条;

Therapeutic potential of rhesus theta (θ) defensin-1 in cystic fibrosis airway infection and inflammation
负责人:
关键词:
Clinical and Experimental Therapeutics cystic fibrosis infection inflammation preclinical drug development
DOI:
doi:10.25549/usctheses-c40-309144
摘要:
of ELF concentrations necessary for antibacterial and anti-inflammatory effects. In line with PK data, we observed antibact
Data from: A novel open access web portal for integrating mechanistic and toxicogenomic study results
负责人:
关键词:
Systems biology;mechanism inference;gene expression analysis;toxicogenomics;toxicity prediction;: toxicogenomics
DOI:
doi:10.5061/dryad.159h65k
摘要:
, leading to relevant mechanistic conclusions. We describe its application by analyzing the effects of several toxicants on liver gene express
Data from: Differential temperature sensitivity of synaptic and firing processes in a neural mass model of epileptic discharges explains
负责人:
关键词:
experimental epilepsy;focal brain cooling
DOI:
doi:10.5061/dryad.vr4sk
摘要:
without affecting the brain’s normal neurological function. Findings suggest a viable treatment for intractable epilepsy cases via an implantable coolin
Data from: Synthesis and characterization of silver nanoparticle-decorated cobalt nanocomposites (Co@AgNPs) and their density-dependent
负责人:
关键词:
DOI:
doi:10.5061/dryad.0bk10qf
摘要:
Magnetic cores loaded with metallic nanoparticles can be promising nano-carriers for successful drug delivery at infectious sites. We report
Data from: Postmarket safety in Canada: are significant therapeutic advances and biologics less safe than other drugs? A cohort study
负责人:
关键词:
small molecule;Health policy;Adverse events;biologics;therapeutic potential;Clinical pharmacology;Drug Safety;Clinical pharmacology
DOI:
doi:10.5061/dryad.fg679
摘要:
Objectives: Examine the probability of new active substances (NASs) approved in Canada between 1 January 1997 and 31 March 2012 acquiring a se
Data from: Age-related differences in bitter taste and efficacy of bitter blockers
负责人:
关键词:
blocker;formulations;taste;Homo Sapiens;medicine;pediatric
DOI:
doi:10.5061/dryad.1jb04
摘要:
) evaluated the effectiveness of two bitter blockers, sodium gluconate (NaG) and monosodium glutamate (MSG), for five food-grade bitter compounds (quinine
Data from: Medical-device recalls in the UK and the device-regulation process: retrospective review of safety notices and alerts
负责人:
关键词:
Field Safety Notice;Medical-device;device-regulation;MDA;clinical data;manufacturer
DOI:
doi:10.5061/dryad.585t4
摘要:
on, and Food and Drug Administration recall system of severity. Results: In total, 2124 field safety notices were issued over the 5-year period, an increase of 1220% (62 in 2006
Data from: Non-industry sponsored preclinical studies on statins yield greater efficacy estimates than industry-sponsored studies: a meta-analysis
负责人:
关键词:
animal experimentation risk of bias conflict of interests meta-analysis
DOI:
doi:10.5061/dryad.754d0
摘要:
in a cohort of published preclinical statin studies. We searched Medline (January 1966 - April 2012) and identified 63 studies evaluating the effects
Data from: Enzymatic degradation of liquid droplets of DNA is modulated near the phase boundary
负责人:
关键词:
DOI:
doi:10.25349/D95G66
摘要:
nt for cellular function. Analogous systems are studied as early-life compartmentalization mechanisms, for applications as protocells, or as drug-delivery vehicles. In ma
Data from: Glucagon-like peptide-1 receptor agonist Liraglutide has anabolic bone effects in ovariectomized rats without diabetes
负责人:
关键词:
DOI:
doi:10.5061/dryad.mf3rb
摘要:
ate that the anti-diabetic drug Liraglutide can exert a bone protective effect even in non-diabetic osteoporotic OVX rats. This protective effect is li

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充